A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro (Q62660588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Paul Proost

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Ingrid De Meester

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Simon Scharpé

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

1753-1756

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

Biological actions and therapeutic potential of the glucagon-like peptides

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Gut adaptation and the glucagon-like peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Structural determinants for activity of glucagon-like peptide-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

CD26, let it cut or cut it down.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

NMR studies of the aggregation of glucagon-like peptide-1: formation of a symmetric helical dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

X-ray analysis of glucagon and its relationship to receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

Presence and release of SR-17 (chromogranin B(586-602)) in the porcine splenic nerve and its enzymatic degradation by CD26/dipeptidyl peptidase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901415-6

10.1016/S0006-2952(02)01415-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445864%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference